Tag Archives: Ironwood Cyclerion spinoff

Ironwood Maiden – Cyclerion Steps Out On Its Own After Spinoff

By |
0 Comment

Everyone was focused on DowDupont’s (DWDP) mega Dow (DOW) spinoff yesterday, but it wasn’t the only show in town. Ironwood Pharmaceuticals (IRWD) also completed the spinoff of Cyclerion Therapeutics (CYCN) that same day. As we previously discussed, Ironwood shareholders should have received one share of Cyclerion stock for every ten shares of IRWD stock owned. That ratio may… Read More »

Ironwood Tries To Hit for The Cyclerion With Spinoff On Deck As Spring Training Winds Down

By |
2 Comments

Born as Microbia over twenty years ago, Ironwood Pharmaceuticals(IRWD) trades just 21% above its 2010 IPO price. It has managed to get to market with LINZESS, a treatment for IBS. Partnered with Allergan(AGN), LINZESS did $761.2 million in 2018 US sales. Now, Ironwood will be spinning off much of its R&D business as Cyclerion. Current Ironwood CEO and… Read More »